The U.S. Securities and Exchange Commission agreed to allow AmerisourceBergen shareholders to vote on a proposal demanding the wholesaler provide more information on steps taken to manage financial and reputational risks associated with the opioid crisis. The agency also allowed another proposal to proceed in which the company would have to disclose if its board clawed back compensation from senior executives due to misconduct.

The decisions are a victory for a coalition of 40 institutional investors that are pressuring drug makers and distributors to investigate how the companies are responding to increased business risks caused by the opioid crisis. The investors noted that AmerisourceBergen (ABC) reached a $16 million settlement last year with the West Virginia attorney general for failing to report suspicious orders of controlled substances

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy